JFD01307SC
CAS No. 51070-56-5
JFD01307SC ( [(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)AMINO] )
Catalog No. M24475 CAS No. 51070-56-5
JFD01307SC is a glutamine synthetase inhibitor. It is anti-tuberculosis agent and acts as a mimic of L-Glutamate and thus target enzymes involved in glutamine biosynthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 35 | In Stock |
|
25MG | 65 | In Stock |
|
50MG | 110 | In Stock |
|
100MG | 177 | In Stock |
|
200MG | 267 | In Stock |
|
500MG | 464 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJFD01307SC
-
NoteResearch use only, not for human use.
-
Brief DescriptionJFD01307SC is a glutamine synthetase inhibitor. It is anti-tuberculosis agent and acts as a mimic of L-Glutamate and thus target enzymes involved in glutamine biosynthesis.
-
DescriptionJFD01307SC is a glutamine synthetase inhibitor. It is anti-tuberculosis agent and acts as a mimic of L-Glutamate and thus target enzymes involved in glutamine biosynthesis.
-
Synonyms[(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)AMINO]
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number51070-56-5
-
Formula Weight193.2
-
Molecular FormulaC6H11NO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:2 mg/mL?(10.35 mM;?ultrasonic and warming and heat to 80°C)
-
SMILESO=C(O)CNC(CC1)CS1(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gyanu Lamichhane, et al. Essential metabolites of Mycobacterium tuberculosis and their mimics. mBio. 2011 Feb 1;2(1):e00301-10.
molnova catalog
related products
-
Nacubactam
Nacubactam (OP 0595, RG 6080, RO 7079901) is a diazabicyclooctane that inhibits class A and C β-lactamases with IC50 of <1 uM.
-
CysHHC10
CysHHC10 is a synthetic antimicrobial peptide (AMP), and exhibits strong anti-microbial properties against both Gram-positive and Gram-negative bacteria.
-
Besifloxacin hydroch...
A fourth-generation fluoroquinolone antibiotic that exhibits a broad spectrum in vitro activity against a wide range of Gram-positive and Gram-negative ocular pathogens.